March 3, 2026Open Access

Concurrent Germline-Somatic Alterations and Associations with Cancer Outcomes: A Systematic Review of Concurrent Data Use

Key Points

Concurrent germline and somatic alterations may significantly improve cancer outcome analysis.
The review indicates that the integration of both data types can lead to better understanding of cancer.
Assessment using a systematic review of existing literature highlights the potential gains.
Improved cancer genetics applications may result from incorporating both alterations from the study design.

Abstract

These findings suggest that planning for concurrent germline-somatic data analysis during the initial design of a translational or clinical study could meaningfully improve current applications in cancer genetics.

Bookmark

View Full Paper

Cite This Study

Pal et al. (Mon,) studied this question.

synapsesocial.com/papers/69a76594badf0bb9e87d9a02 https://doi.org/https://doi.org/10.21203/rs.3.rs-8296996/v1

Bookmark

View Full Paper